Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Pharmacokinetics and Safety Study of Oral Soticlestat in Participants With Moderate or Mild Hepatic Impairment and Normal Hepatic Function

NCT05098054 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05098054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05098054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Pharmacokinetics and Safety Study of Oral Soticlestat in Participants With Moderate or Mild Hepatic Impairment and Normal Hepatic Function
Lead sponsor
Takeda
Phase
Phase 1
Overall status
Completed
Start date
October 29, 2021
Completion date
June 7, 2022
Enrollment
36 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, hepatic impairment